# Insulet Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/insulet

- Industry: Healthcare
- Headquarters: Bedford, US
- Total disclosed funding: $119M
- Latest round: Series E (Feb 3, 2006)
- Investors on record: 9

## About

Founded in 2000, Insulet Corporation is a medical device company, engages in the development, manufacture, and marketing of insulin infusion systems.

## Funding rounds

- Series E, Feb 3, 2006, $50M — Alta Partners, OrbiMed Advisors, Prism Venture Management, Versant Ventures, SV Health Investors, FirstMark Capital, MDT Advisers
- Series D, Mar 4, 2004, $36M — Alta Partners, Prism Venture Management, Versant Ventures, SV Health Investors, Oakwood Medical Investors, FirstMark Capital
- Series C, Oct 7, 2002, $22M — Oakwood Medical Investors, Pequot Ventures
- Series A, Aug 8, 2001, $11M — Prism Venture Management, Versant Ventures, SV Health Investors

## Investors

- Prism Venture Management (https://capitalatlas.ai/funds/prism-venture-management) — Series A, Series D, Series E
- Versant Ventures (https://capitalatlas.ai/funds/versant-ventures) — Series A, Series D, Series E
- SV Health Investors (https://capitalatlas.ai/funds/sv-health-investors) — Series A, Series D, Series E
- Oakwood Medical Investors (https://capitalatlas.ai/funds/oakwood-medical-investors) — Series C, Series D
- Pequot Ventures (https://capitalatlas.ai/funds/pequot-ventures) — Series C
- Alta Partners (https://capitalatlas.ai/funds/alta-partners) — Series D, Series E
- FirstMark Capital (https://capitalatlas.ai/funds/firstmark-capital) — Series D, Series E
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series E
- MDT Advisers — Series E